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INTRODUCTION
The term ‘‘polypoid lesion of the gallbladder (PLG)’’ re-
fers to any elevated lesion of the mucosal surface of the gall-
bladder (1). The presenting symptoms of PLG are non spe-
cific and vague, and in many cases asymptomatic. For such
reason, PLGs are often detected incidentally. Along with ea-
sier accessibility to routine medical check-ups, recent advan-
cements in imaging modalities such as ultrasonography (USG)
and endoscopic ultrasonography, the detection of PLG is be-
coming more frequent. Although there are some differences
according to reports, the prevalence of PLG in healthy sub-
jects is 3% to 7%, and PLG are found in 2-12% of cholecys-
tectomy specimens (2).
PLG is classified according to the classification proposed by
Christensen and Ishak (1) in 1970. They are classified into
benign tumors such as adenoma, benign pseudotumors such
as adenomatous hyperplasia, adenomyoma, inflammatory
polyp, cholesterol polyp, and malignant polyps such as ade-
nocarcinoma. The reported prevalence of malignant polyps
among PLGs varies from 0% to 27% (3). It is well known
that gallbladder cancer at an advanced stage reveals poor prog-
nosis even with radical resection, thus early detection and
early surgical intervention is particularly important. Despite
many available imaging modalities such as USG, computed
tomography (CT), magnetic resonance imaging, endoscopic
retrograde cholangiography, and endoscopic ultrasonography,
it is still difficult to differentiate benign polyp and malignant
polyp in PLGs. Therefore treatment plan of PLG should be
established with consideration of many clinicopathologic char-
acteristics altogether with information acquired from imag-
ing studies.
The reported risk factors for malignant PLG are age of the
patient, total number of polyp, morphology, size, associated
gallstone, and symptomatic polyp (4-9). The purpose of this
study is to identify risk factors of malignant PLG by compar-
ing the clinicopathologic characteristics of benign and mali-
gnant polyps confirmed by cholecystectomies. Thereby, an
adequate treatment may be provided to patients with PLG.
MATERIALS AND METHODS
Data of 396 patients who were confirmed to have PLG
through cholecystectomy at Seoul National University Hos-
pital between October 1992 and December 2005 were re-
viewed, Among patients who underwent cholecystectomy
for PLG, those with definite evidence of malignancy such as
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Clinicopathologic Features of Polypoid Lesions of the Gallbladder and
Risk Factors of Gallbladder Cancer
It is difficult to differentiate benign and malignancy in polypoid lesions of the gallblad-
der (PLG) by solely depending on imaging studies. Therefore clinicopathologic fea-
tures of benign and malignant polyps are compared in an attempt to identify the risk
factors of malignant polypoid lesions. The medical records of 291 patients who were
confirmed to have PLG through cholecystectomy were reviewed and analyzed for
age, sex, symptom, associated gallstone, morphology of PLG, size of PLG, number
of PLG, and preoperative tumor markers. Benign PLG was found in 256 patients
(88.0%) and malignant PLG in 35 patients (12.0%). Compared with benign group,
the malignant group were older (61.1 yr vs. 47.1 yr, P<0.001), more often accom-
panied with symptoms (62.9% vs. 28.9%, P<0.001). Malignant PLG tended to be
sessile (60.0% vs. 10.5%, P<0.001), larger (28.0 mm vs. 8.6 mm, P<0.001) and
single lesion (65.7% vs. 44.1%, P<0.016). Age over 60 yr (P=0.021, odds ratio [OR],
8.16), sessile morphology (P<0.001, OR, 7.70), and size over 10 mm (P=0.009,
OR, 8.87) were identified as risk factors for malignant PLG. Careful decision mak-
ing on therapeutic plans should be made with consideration of malignancy for patients
over 60 yr, with sessile morphology of PLG, and with PLG size of over 10 mm.
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temic metastasis on preoperative USG or CT were exclud-
ed, and the study was limited to 291 patients whose infor-
mation on clinical and PLG characteristics was well docu-
mented. Information on age, sex, symptom, associated gall-
stone, polyp morphology, size, polyp number, and preopera-
tive serum chorioembryonic antigen (CEA) and carbohydrate
antigen 19-9 (CA 19-9) were retrospectively reviewed. 
The patients were divided into benign group and malig-
nant group according to their histopathologic results. Chi-
square test and Student t-test statistic analysis was carried
out where appropriate to investigate whether significant dif-
ferences in clinicopathologic characteristics exist between
two groups. For continuous variables such as age and PLG
size, receiver operation characteristic (ROC) curve was used
to acquire cut-off value for stratification. In order to identify
risk factors for gallbladder cancer, the odds ratio as obtained
using multiple logistic regression analysis in 95% confidence
interval on clinicopathologic characteristics that showed si-
gnificant difference. All statistic values with P value <0.05
were considered significant. SPSS 13.0 for Windows (Chica-
go, IL, U.S.A.) authorized for Seoul National University Hos-
pital was used for statistic analysis. 
RESULTS
Demographic findings and clinical characteristics
Among 291 patients, 140 (48.1%) were male and 151
(51.9%) were female. The mean age of the patients was 48.8
±12.6 yr. Of the total patients, 195 patients  (67.0%) were
asymptomatic, and 61 patients (21.0%) had associated stone.
The general characteristics of PLGs include 48 sessile polyps
(16.5%), 136 single polyps (46.7%), and mean size was 10.89
±0.57 mm. The demographics and clinical characteristics
are summarized in Table 1. 
The polyps were detected by USG alone in 142 patients
(48.8%), computed tomography alone in 69 patients (23.7%),
by both USG and computed tomography in 80 patients (27.5
%). Most of the USG in the earlier phase of this study was a
plain USG, but in more recent times many patients were ex-
amined with high resolution USG. In a small portion of pa-
tients, endoscopic USG was carried out as an adjunctive ex-
amination. 
Of 291 patients, benign polyp was discovered in 256 pa-
tients (88.0%) and malignant polyp in 35 patients (12.0%).
Ninety cases (30.9%) were adenoma, 6 cases (2.1%) adeno-
matous hyperplasia, 6 cases (2.1%) adenomyomatosis, 5 cases
(1.7%) inflammatory polyp, 149 cases (51.2%) cholesterol
polyp, 33 cases (11.3%) adenocarcinoma, and 2 cases (0.7%)
metastatic cancer (Table 2). The 2 cases of metastatic cancer
appearing as PLG are hepatocellular carcinoma and malig-
nant melanoma each. 
The depths of invasion in 35 malignant polyps were Tis in
5 cases, T1a in 11 cases, T1b in 6 cases, T2 in 12 cases, and
T3 in 1 case. Laparoscopic cholecystectomy was done in 14
cases, open cholecystectomy in 1 case, extended cholecystec-
tomy in 18 cases, palliative bypass in 1 case, and 1 pylorus
preserving pancreaticoduodenectomy due to concurrent co-
mmon bile duct cancer. In patients who underwent laparo-
scopic cholecystectomy, all depths of invasion were Tis and
T1, except for 1 patient whose depth was T2.
Metastatic hepatocellular carcinoma was detected in a 64
yr-old male patient with underlying non-B, non-C liver cir-
rhosis. The patient was diagnosed with hepatocellular carci-
noma in S4 and S8 which was treated with a cycle of trans-
arterial chemoembolization 2 yr prior to PLG detection. The
other metastatic gallbladder mass was in a 28 yr-old male pa-
tient. He underwent a wide excision for a 1.5 cm sized nevus
on his left anterior chest which was confirmed as malignant
melanoma with a clear resection margin on 9 months prior
to the laparoscopic cholecystectomy due to the PLG.
Risk factors of gallbladder cancer
The clinical and pathological features of the patients under-
482 W. Kwon, J.-Y. Jang, S.E. Lee, et al.
Sex M 140 (48.1%)
F 151 (51.9%)
Mean age* (yr) 48.8±12.6 (19-83)
Symptom Asymptomatic 195 (67.0%)
Symptomatic 96 (33.0%)
Associated stone Stone 61 (21.0%)
No stone 230 (79.0%)
Morphology Sessile 48 (16.5%)
Pedunculated 243 (83.5%)
Multiplicity Single 136 (46.7%)
Multiple 155 (53.3%)
Mean size* (mm) 10.89±0.57 (1-60)
Table 1. Demographic findings and clinical characteristics of
the 291 study subjects
*Continuous variables are described as mean±SEM (standard error of
mean).
Histopathologic diagnosis  Number (%)
Benign Benign tumors Adenoma 90 (30.9)
Benign pseudo- Adenomatous hyperplasia 6 (2.1)
tumors Adenomyoma 6 (2.1)
Inflammatory polyp 5 (1.7)
Cholesterol polyp 149 (51.2)
Malignant Adenocarcinoma 33 (11.3)
Metastatic carcinoma 2 (0.7)
Total 291 (100)
Table 2. Histopathologic diagnosis of 291 polypoid lesions of
gallbladderwent univariate analysis to investigate statistical differences
between benign and malignant PLG. Then using the features
that showed significant differences in univariate analysis, mul-
tiple logistic regression was done to identify the risk factors
for gallbladder cancer.
The results of the univariate analysis are summarized in
Table 3. In malignant group, there were 12 males (34.3%)
and 23 females (65.7%). In benign group, there were 128
males (50.0%) and 128 females (50.0%). The male-to-female
ratios in malignant and benign group were 1:1.92 and 1:1,
respectively, showing female predominance in malignant
group. However, sexual difference in both group was statis-
tically insignificant (P=0.081). The mean age of patients was
61.1±2.0 yr in malignant group, 47.1±0.7 yr in benign
group. The patients were significantly older in malignant
group (P<0.001). When the frequency of malignant polyp
was obtained in accordance with age groups, it tended to in-
crease with age (Table 4).
One hundred and ninety-five patients (67.0%) with PLG
were asymptomatic and detected incidentally on routine med-
ical check-up, and the remaining 96 patients (33.0%) discov-
ered PLG during work-up for symptoms such as abdominal
pain. Whereas only 28.9% (n=74) of patients sought medi-
cal attention due to a symptom in benign group, 62.9% (n=
22) of patients in malizgnant group visited medical profes-
sionals due to presenting symptoms (P<0.001).
Associated gallstone was discovered in 21.5% (n=55/256)
and 17.1% (n=6/35) of patients in benign and malignant
group, respectively. Associated gallstone was more frequent in
benign group, but without statistical significance (P=0.554). 
The information on the morphology, size, and multiplici-
ty of PLG were primarily based on pathology reports. There
were 229 (89.5%) pedunculated polyps and 27 (10.5%) se-
ssile polyps in benign group. On the other hand, among 35
patients in malignant group, there were 14 (40.0%) pedun-
culated polyps and 21 (60.0%) sessile polyps. The frequency
of sessile polyp was greater in malignant group compared
with benign group (P<0.001).
The mean size was significantly larger in malignant group,
the mean size (±standard error of mean [SEM]) being 8.56
±0.36 mm and 27.97±2.46 mm for benign and malig-
nant group, respectively (P<0.001). The size of malignant
polyp ranged between 8 mm and 60 mm (Table 5), and no-
tably, there were 2 malignant polyps with the size less than
10-8 mm and 9 mm, each.
In benign group, 143 cases (55.9%) demonstrated multi-
ple polyps and 113 cases (44.1%) were single lesion. In mali-
gnant group, only 12 cases (34.3%) were multiple lesions
and 23 cases (65.7%) were single lesion. Single lesion was
more frequent in malignant group (P=0.016).
Preoperative serum CEA and CA 19-9 were measured in
most of the patients. Serum CEA was studied in 192 patients
of benign group and in 35 of malignant group. In the instance
of serum CA 19-9, it was studied in 185 of benign group and
35 of malignant group. The average CEA level (±SEM, ref-
erence range: 0-5 ng/mL) in benign group and malignant
group was 1.89±0.11 ng/mL and 2.01±0.44 ng/mL, res-
pectively (P=0.685). Only 5.7% (n=11) of benign group and
2.9% (n=1) of malignant group had exceeded the reference
level of CEA which also showed no significant difference bet-
ween the groups (P=0.697). The average CA 19-9 level (±
SEM, reference range: 0-37 IU/mL) in the malignant group
(21.49±7.13 IU/mL) was higher than that of the benign
group (12.14±1.72 IU/mL), although statistically insignif-
icant (P=0.210). Nine patients (4.9%) in benign group and
3 patients (8.6%) in malignant group displayed CA 19-9
level above the reference level, which also lacks statistic sig-
nificance (P=0.412).
The features that showed statistically significant difference
between benign and malignant group were age, present sym-







� 61.1±2.0 47.1±0.7 <0.001
Sex (M:F) 1:1.92 1:1 0.081*
Symptomatic polyp 62.9% 28.9% <0.001
Associated stones 17.1% 21.5% 0.554*
Sessile morphology 60.0% (21/35) 10.5% (27/256) <0.001
Polyp size (mm)
� 27.97±2.46 8.56±0.36 <0.001
Single polyp 65.7% 44.1% 0.016
CEA (ng/mL)
� 1.89±0.11 2.01±0.44 0.685*
(n=35) (n=192)
CA 19-9 (IU/mL)
� 21.49±7.13 12.27±1.72 0.210*
(n=35) (n=185)
Table 3. Comparison of clinicopathologic characteristics bet-
ween malignant and benign polyp groups
Age (yr) Malignant polyp Total PLG %
<40 2 74 2.7
40-49 4 83 4.8
50-59 8 63 12.7
≥60 21 71 29.6
Table 4. Frequency of malignant polyp according to age groups
*P<0.001
PLG, polypoid lesions of gallbladder. 
Size (mm) Malignant polyp Total PLG %
<10 2 156 1.3
10-19 9 94 9.6
≥20 24 41 58.5
Table 5. Frequency of malignant polyp according to size groups
*P<0.001.
PLG, polypoid lesions of the gallbladder.
*Statistically not significant; 
� Continuous variables are described as mean
SEM (standard error of mean).
CEA, chorioembryonic antigen; CA, carbohydrate antigen.ptom, morphology of polyp, size of polyp, single lesion. How-
ever, sex, associated gallstone, preoperative serum CEA and
CA 19-9 were statistically insignificant.
Multiple logistic regression was carried out using age, sym-
ptom, polyp morphology, polyp size, and multiplicity of PLG,
which demonstrated statistical significant difference between
the two groups, as covariables. 
For continuous variables such as age and polyp size, the cut-
off values were obtained by ROC curve in order to categorize
the values into groups. The cut-off values were 57.5 yr of age
and 12.5 mm for the size. The sensitivity and the specificity
of the cut-off values were 0.77, 0.73 for age, and 0.83, 0.83
for size, respectively. The cut-off values were rounded off to
60 yr and 10 mm into denary scale to make the clinical appli-
cation of the values more convenient. The sensitivity and the
specificity of the rounded off selected cut-off value were 0.60,
0.81 for age, and 0.83, 0.78 for size, respectively (Fig. 1, 2). 
The result of the multiple logistic regression identified age
over 60 yr, sessile morphology, and polyp size over 10 mm as
the risk factors of the gallbladder cancer as summarized in
Table 6.
Frequency of malignant PLG in relation to risk factors
The frequency of malignant polyps according to the num-
ber of risk factor criteria (age ≥60 yr, sessile morphology,
size ≥10 mm) that patient met was reviewed. The frequen-
cy of malignant polyp in patients who met all 3 criteria was
77.8% (14/18), 2 criteria was 28.6% (12/42), and only 1 cri-
teria was 7.8% (9/116). For those who did not have any risk
factors, there was not a single case of malignant polyp in 115
patients (Table 7).
DISCUSSION
Most of PLGs are asymptomatic and even if there are symp-
toms, they are non-specific and vague in their nature. There-
484 W. Kwon, J.-Y. Jang, S.E. Lee, et al.
CI, confidence interval; PLG, polypoid lesions of the gallbladder.
Odds ratio
95% CI
Lower limit Upper limit
P value
Age (yr) <40 0.104
40-49 3.14 0.273 0.41 24.37
50-59 6.43 0.057 0.95 43.56
≥60 8.16 0.021 1.38 48.44
Symptom Symptomatic 2.21 0.137 0.78 6.32
Morphology Sessile 7.70 <0.001 2.48 23.95
Size (mm) <10 <0.001
10-19 8.87 0.009 1.72 45.72
≥20 77.03 <0.001 13.83 429.02
Multiplicity Single PLG 0.97 0.951 0.31 3.00
Table 6. Multiple logistic regression to identify risk factors of gallbladder cancer
True cut-off value : 57.5 yr
Sensitivity: 077
Specificity: 0.73
Selected cut-off value: 60.0 yr
Sensitivity: 0.60
Specificity: 0.81
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Fig. 1. ROC curve to determine the cut-off value of age (P<0.001). Fig. 2. ROC curve to determine the cut-off value of PLG size (P<
0.001).fore, in the past, only a few patients sought medical attention.
However, owing to the development of imaging modality
and increased accessibility to medical system, the detection
rate of PLG is increasing. The prevalence of PLG in normal
population varies from 3% to 7% and PLGs are observed in
2% to 12% of cholecystectomized specimens (3). The report-
ed incidences in Danish, Japanese, and Taiwanese population
are 4.3%, 5.2%, and 6.9% (10-12), respectively. Not rare as
it is, the importance and the treatment strategy of PLG is
still not well understood.
Even though most of the PLGs are benign in nature, malig-
nant polyps are present in some cases. Because advanced gall-
bladder cancer displays poor prognosis, early detection and
appropriate early measure is important for curative treatment
and long-term survival. This fact emphasizes the clinical sig-
nificance of PLGs. Also, though controversial, there are many
reports advocating malignant transformation of gallbladder
adenoma as in the adenoma-adenocarcinoma sequence of co-
lon cancer (13, 14). Therefore better understanding of clini-
copathologic characteristics and further investigations into
risk factors for malignant polyps is necessary for establishment
of appropriate treatment strategies.
The histopathologic distribution of PLG was cholesterol
polyp in 51.2%, adenoma in 30.9%, and malignancy in
12.0% in this study. This result is similar to previous reports
on histologic distribution of PLG (9). The reported preva-
lence of malignant polyp is 0% to 27% (3). Terzi et al. (7)
observed 26% malignant polyp in 100 patients, and Kubota
et al. (6) reported 22% malignant prevalence. In 2 studies
on Chinese population, the reported prevalence was 5.7%
and 5.8% (4, 15). The large discrepancy of prevalence of ma-
lignancy among investigators is probably due to small sam-
ple size and difference in patient selection, and the accepted
general prevalence of malignancy is estimated at around 3%
to 8% (3).
The first line imaging modality for PLG is USG with its
general sensitivity ranging from 36% to 90%, reaching 99%
(3). Other conventionally used image modalities include oral
cholecystography, computed tomography, endoscopic retro-
grade cholangiopancreatography which are all known to be
inferior to USG (5). But many other new imaging studies
such as enhanced helical computed tomography, endoscopic
USG, magnetic resonance cholangiography, and positron
emission tomography are being introduced and applied into
practice for detection of PLG or differential diagnosis of PLG.
In the current study, the mean age of malignant group was
significantly older than benign group. This result is in accor-
dance with previous Korean report (16). Also a report that
many patients with malignant polyps are over 50 yr of age
(5) and another report that malignancy risk of PLG increases
with age (13) indicate that old age is an important feature
of malignant polyp.
Concerning sexual difference in the incidence of PLG, some
authors claim male predominance (11, 12, 17), whereas oth-
ers observed female predominance (4, 13). In this study, female
predominance of PLG was observed, and although statisti-
cally insignificant, malignant PLGs occurred more frequent-
ly in female.
The clinical symptom of PLG was previously reported to
be non-specific and not to differ between benign and malig-
nant polyps. Even if the symptom is present, it is usually
similar to that of symptomatic calculous cholecystitis (7, 18).
In the present study, 67.0% of all patients were asymptomatic
and 33.0% were symptomatic-abdominal pain and epigas-
tric discomfort being the most frequent. Symptoms were sig-
nificantly associated with malignant polyp compared with
benign polyp. The association of symptom and presence of
associated gallstone was separately analyzed. Significant asso-
ciation of symptom to associated gallstone was not found (P=
0.235). However, symptomatic cases tended to increase with
the increase in polyp size (P=0.001). Therefore a speculation
can be made that symptom may be associated with the size
of the polyp rather than the association of gallstone.
Kubota et al. (6) claimed that sessile morphology is one
of the important factors that suggest malignancy, and some
scholars also asserted that sessile morphology is a risk factor
of gallbladder cancer (9). In this study, sessile morphology
was more dominant in the malignant group. Early gallblad-
der cancer is defined as those confined to mucosa or muscle
layer, and the lesions can have several shapes, including pe-
dunculated, sessile, superficial raised, and flat (19). And one
of the possible explanations for frequent sessile morphology
in malignant PLG may be that most gallbladder cancer ari-
ses in-situ from flat, dysplastic epithelium (20).
It is generally agreed upon that polyp size over 10 mm is
a predicting factor of malignancy. Koga et al. (21) and Ku-
ota et al. (6) previously reported 37% to 88% prevalence of
malignancy in PLG over 10 mm. Csendes et al. (22) obser-
ved no adenocarcinoma and no progression to malignancy in
PLGs less than 10 mm during mean period of 71 months
follow-up. In the current study, the mean polyp size of malig-
nant polyps was by far larger than benign polyps (27.97 mm
vs. 8.56 mm). Prevalence of malignant polyp in polyps over
10 mm was 24.4% (33/135). Although this 24.4% preva-
lence is not in accordance with the 37 to 88% prevalence men-
tioned above, it is similar to a Korean report of 22.8% preva-
lence (9). There is a general agreement that polyp size over





3 (+)  14/18 77.8
2 (+)  12/42 28.6
1 (+)  9/116 7.8
0 (+)  0/115 0
Table 7. Frequency of malignant polyp according to correspond-
ing number of risk factors, of age, size of PLG and sesile lesion
PLG, polypoid lesions of the gallbladder.10 mm is a risk factor for malignant polyp (4, 5, 7). How-
ever, it is worthy of noting that 3 cases and 1 case of malig-
nant polyp less than 10 mm has been reported in two stud-
ies (9, 16). Additionally, 2 malignant polyps of less than 10
mm was observed in this study too. Therefore, clinicians
should have caution that there may still be malignant polyps
even if the sizes of the polyp are less than 10 mm, and the
possibility of malignant polyp should not be ruled out on
the basis of size alone. In the present study, malignant polyps
tended to be a single lesion compared with benign polyps.
The similar findings were reported by many others scholars
(4-6, 23).
Tumor markers such as CEA and CA 19-9 increases in ga-
llbladder cancer, and CA 19-9 - having high clinical signifi-
cance with its sensitivity of 60% to 70% in biliary malignan-
cy - is used in diagnosing gallbladder cancer in adjunct to imag-
ing modalities in particular (24). In this study, the mean serum
level of CEA and CA 19-9 was within the reference range in
both benign and malignant group, and no significant differ-
ences existed between two groups. Furthermore, there was
no significant difference in the prevalence of patients above
the reference range in both groups. Therefore it may be stated
that serum tumor markers have little role in differentiating
benign and malignancy in PLGs. The impracticality of the
tumor markers in differential diagnosis may be explained by
the fact that most of the malignant polyps in PLGs are early
gallbladder cancers.
Risk factors claimed by other authors are reviewed. Yeh
et al. (4) identified age over 50 yr and polyp size over 10 mm
as the independent risk factors of malignant polyps. Yang et
al. (5) reported that size over 10 mm, single PLG, the pres-
ence of gallstone, age over 50 yr, and clinical symptoms were
associated with malignancy. Kubota et al. (6) proposed ses-
sile polyp, isoechogenicity with the liver parenchyma, and
rapid growth were also important factors predicting malig-
nancy. Terzi et al. (7) noted age over 60 yr, size over 10 mm,
and associated gallstone as the risk factors for malignancy. He
et al. (8) proclaimed that cholecystectomies should be indi-
cated in polyps with size over 10 mm and age over 50 yr.
Jang et al. (9) identified age, polyp size, polyp morphology
as the risk factors. In the current study, using significant fea-
tures of malignant polyp-age, presence of symptom, polyp
morphology, polyp size, and multiplicity of PLG-as covari-
ables, multiple logistic regression was carried out. The result
of the analysis identified age over 60 yr, sessile morphology,
and polyp size over 10 mm as the risk factors for malignant
polyp.
No malignant polyp was found in patients without any
risk factors identified in the current study. However, 7.8%,
28.6%, and 77.8% of PLGs were malignant in patients with
single risk factor, 2 risk factors, and all 3 risk factors, respec-
tively. Therefore, for the risk factors identified in the study,
it may be speculated that the risk for malignancy increases
as more risk factors are identified on the patient’s side. And
this speculation may be used as a guidance in deciding the
therapeutic strategy of patients with PLG.
In summary, age over 60 yr, sessile morphology, and polyp
size over 10 mm was identified as the risk factors for malig-
nant polyps in PLGs. Further, the frequency of malignant
polyps in patients with all 3 risk factors was 77.8%, 28.6%
in patients with 2 risk factors, and 7.7% in patients with sin-
gle risk factor. Therefore, clinician should evaluate patients
with PLG with the possibility of malignancy in mind if the
patient has one or more risk factors. Surgical intervention
should be considered in patient with symptomatic PLG and
in patients with one or more risk factors. 
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